carmofur has been researched along with Uterine Cervical Neoplasms in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (50.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Matsui, Y; Okudaira, Y; Sawada, M | 1 |
Ikeda, M; Kubo, H; Nakajima, H; Noda, K; Okamura, S; Sugawa, T; Sugimoto, O; Teshima, K; Yamabe, T; Yamagata, S | 1 |
1 trial(s) available for carmofur and Uterine Cervical Neoplasms
Article | Year |
---|---|
[Long-term administration of carmofur as a post-operative adjuvant chemotherapy for cervical adenocarcinoma. Cervical Adenocarcinoma Cooperative Research Association].
Topics: Adenocarcinoma; Administration, Oral; Adult; Aged; Antineoplastic Agents; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Female; Fluorouracil; Humans; Middle Aged; Neoplasm Recurrence, Local; Postoperative Period; Registries; Survival Rate; Uterine Cervical Neoplasms | 1994 |
1 other study(ies) available for carmofur and Uterine Cervical Neoplasms
Article | Year |
---|---|
Concentrations of a new antitumor agent, 1-hexylcarbamoyl-5-fluorouracil in serum and gynecologic tumor tissue.
Topics: Antineoplastic Agents; Female; Fluorouracil; Humans; Ovarian Neoplasms; Uterine Cervical Neoplasms | 1983 |